Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia.

Autor: Mahajan, S. A.1, Nandagopal, N.1, Soni, M.2, Annigeri, R. A.1 r_annigeri@yahoo.com
Zdroj: Indian Journal of Nephrology. Nov/Dec2015, Vol. 25 Issue 6, p366-369. 4p.
Databáze: Academic Search Ultimate